Login / Signup

'Efficacy of anti-IL-23 and anti-IL-17 after adalimumab failure in psoriatic patients'-response to Yu et al.

Luca MastorinoM OrtoncelliP DapavoSimone RiberoPietro Quaglino
Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Keyphrases
  • end stage renal disease
  • rheumatoid arthritis
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • peritoneal dialysis
  • prognostic factors